GGrantIndex
Sort

39,280 grants matching leukemia

High resolution dissection of oncogene enhancer networks via CRISPR screening and live-cell imaging.

$442,399
Lei Stanley Qi · Stanford University · R01 · FY2023 · CA

New Ubiquitin-Proteasome System Components that Protect against Proteotoxicity

$442,396
John W Hanna · Brigham And Women'S Hospital · DP5 · FY2014 · OD

Project 4 - Genomics of TP53-mutant AML.

$442,330
Daniel C Link · Washington University · P01 · FY2020 · CA

Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions

$442,311
Binghe Wang · Georgia State University · R01 · FY2017 · CA

Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions

$442,311
Binghe Wang · Georgia State University · R01 · FY2016 · CA

Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions

$442,311
Binghe Wang · Georgia State University · R01 · FY2018 · CA

Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions

$442,311
Binghe Wang · Georgia State University · R01 · FY2015 · CA

Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy

$442,225
Paul Michael Armistead · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA

From the Past to the Future: Chimeric Antigen Receptor T cells for Lymphoid Malignancies

$442,180
Joseph Anthony Fraietta · University Of Pennsylvania · P01 · FY2023 · CA

Regulation of Chromatin Structure Dynamics in Hematopoietic and Leukemic Stem Cel

$442,156
Camilla Forsberg · University Of California Santa Cruz · R01 · FY2016 · HL

Mechanism and regulation of DNA interstrand cross-link repair

$442,145
Johannes Walter · Harvard Medical School · R01 · FY2024 · HL

Targeting NSD1 in leukemia

$442,141
Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2022 · CA

Project 3 - Genomics of Secondary AML Progression.

$442,088
Matthew J Walter · Washington University · P01 · FY2020 · CA

VISIBLE ANIMAL MODELS OF NEOPLASTIC DISEASE

$442,086
Stanford University · R33 · FY2000 · CA

Strategies to improve the adoptive transfer of T cells

$442,047
Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA

Dissecting and Predicting Lethal Prostate Cancer using Biologically Informed Artificial Intelligence

$442,025
Eliezer M Van Allen · Dana-Farber Cancer Inst · P50 · FY2024 · CA

Project 2: Defining the Role of Megakaryocyte Abnormalities in the Progression of Primary Myelofibrosis

$442,007
John D Crispino · Icahn School Of Medicine At Mount Sinai · P01 · FY2024 · CA

Mapping cancer micro-environments for acute leukemia

$441,979
Iannis Aifantis · New York University School Of Medicine · R01 · FY2019 · CA

Targeting NSD1 in leukemia

$441,957
Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2023 · CA

RUNX3 in Vascular Wall Remodeling

$441,861
Xia Guo · University Of Texas Hlth Ctr At Tyler · R01 · FY2025 · HL

Functional Study of Native and Synthetic Nuclei

$441,835
Douglass J Forbes · University Of California, San Diego · R01 · FY2006 · GM

Chromatin Modifications by Histone Ubiquitination and Methylations

$441,732
Ali Shilatifard · Stowers Institute For Medical Research · R01 · FY2012 · GM

Solid State Radiation Chemistry Of DNA

$441,695
William A Bernhard · University Of Rochester · R01 · FY2007 · CA

Solid State Radiation Chemistry Of DNA

$441,638
William A Bernhard · University Of Rochester · R01 · FY2006 · CA

Molecular Pathogenesis of AF10-Rearranged Leukemias

$441,618
Aniruddha J. Deshpande · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · CA